We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

45 hedge funds and large institutions have $34.2M invested in Cumberland Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

9% more capital invested

Capital invested by funds: $31.4M → $34.2M (+$2.82M)

0% more funds holding

Funds holding: 45 → 45 (0)

Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
16
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$351K
2
Renaissance Technologies
Renaissance Technologies
New York
+$189K
3
PM
Platinum Management
New York
+$127K
4
Deutsche Bank
Deutsche Bank
Germany
+$63.2K
5
AIS
AlphaOne Investment Services
Pennsylvania
+$50.3K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$2.68M
2
GHA
GW Henssler & Associates
Georgia
-$513K
3
UCFA
United Capital Financial Advisors
Texas
-$426K
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$300K
5
BIT
BlackRock Institutional Trust
California
-$84.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
Coldstream Capital Management
Washington
$127K -$29.9K -5,825 -21%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$99K +$1.54K +300 +2%
Deutsche Bank
28
Deutsche Bank
Germany
$77K +$63.2K +12,314 +1,759%
DAM
29
Delta Asset Management
Tennessee
$66K – – –
Ameriprise
30
Ameriprise
Minnesota
$65K +$6.67K +1,300 +14%
Cambridge Investment Research Advisors
31
Cambridge Investment Research Advisors
Iowa
$60K – – –
BA
32
BlackRock Advisors
Delaware
$37K – – –
NFA
33
Nationwide Fund Advisors
Ohio
$23K – – –
OC
34
Oakworth Capital
Alabama
$18K – – –
Creative Planning
35
Creative Planning
Kansas
$18K +$6.67K +1,300 +76%
PNC Financial Services Group
36
PNC Financial Services Group
Pennsylvania
$18K +$10.3K +2,000 +200%
Citigroup
37
Citigroup
New York
$14K -$2.06K -401 -14%
BIM
38
BlackRock Investment Management
Delaware
$12K – – –
Federated Hermes
39
Federated Hermes
Pennsylvania
$8K +$3.71K +722 +133%
UBS Group
40
UBS Group
Switzerland
$6K +$5.05K +984 New
BRWM
41
B. Riley Wealth Management
Tennessee
$5K – – –
TRCT
42
Tower Research Capital (TRC)
New York
$1K +$755 +147 New
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 – – –
Wellington Management Group
44
Wellington Management Group
Massachusetts
– -$82K -16,631 Closed
WA
45
WealthTrust-Arizona
Arizona
– -$32K -6,448 Closed
LTFS
46
Ladenburg Thalmann Financial Services
Florida
– +$62 +12 New
SEI Investments
47
SEI Investments
Pennsylvania
– +$980 +191 New
1
2

CPIX Hedge Fund Activity: Q4 2014 in Review

45 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2014, worth a combined $34.2M — up 9% from $31.4M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CPIX positions and 3 closed out — a net gain of 2 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was Millennium Management, adding an estimated $351K. The largest seller was Ariel Investments, cutting an estimated $2.68M.

  • 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $34.2M of Cumberland Pharmaceuticals stock for Q4 2014, up 9% quarter-over-quarter.
  • 5 funds opened new Cumberland Pharmaceuticals positions in Q4 2014 and 3 closed out, a net change of +2 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2014 was Millennium Management, an estimated $351K added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2014 was Ariel Investments, an estimated $2.68M sold.

Based on aggregated 13F filings for Q4 2014.